P Hu Selected Research

P Hu Research Topics

Disease

21	Chronic Hepatitis B 04/2024 - 11/2007
14	Neoplasms (Cancer) 05/2022 - 02/2000
7	Infections 10/2023 - 09/2002
7	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 11/2006
4	Hepatitis B 09/2021 - 03/2016
4	Inflammation (Inflammations) 06/2021 - 12/2001
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021 - 12/2020
3	Hepatitis C 03/2017 - 03/2016
3	Necrosis 09/2013 - 01/2001
3	Breast Neoplasms (Breast Cancer) 10/2012 - 01/2000
3	Postoperative Pain 06/2011 - 06/2008
2	Genomic Instability 08/2023 - 06/2001
2	Adenocarcinoma 05/2022 - 02/2022
2	Hemorrhage 02/2022 - 11/2018
2	Liver Diseases (Liver Disease) 01/2022 - 12/2020
2	Nasopharyngeal Carcinoma 01/2022 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2018
2	Fibrosis (Cirrhosis) 06/2021 - 01/2016
2	Non-alcoholic Fatty Liver Disease 07/2019 - 04/2017
2	Chronic Hepatitis C 03/2017 - 11/2016
2	Carcinogenesis 05/2015 - 09/2002
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 04/2012 - 01/2010
2	Hearing Loss (Hearing Impairment) 01/2012 - 04/2001
2	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 06/2001 - 11/2000
1	Type 2 Diabetes Mellitus (MODY) 01/2024
1	Chemical and Drug Induced Liver Injury 01/2024
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2023
1	Asthma (Bronchial Asthma) 03/2023
1	Crohn Disease (Crohn's Disease) 02/2023
1	Tinea (Ringworm) 01/2023
1	Dermatomycoses 01/2023
1	Esophageal Squamous Cell Carcinoma 10/2022
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 05/2022
1	Flatulence 05/2022
1	Postoperative Hemorrhage 05/2022
1	Hiatal Hernia 05/2022
1	Pneumonia (Pneumonitis) 05/2022
1	Neoplasm Metastasis (Metastasis) 05/2022
1	Stomach Neoplasms (Stomach Cancer) 02/2022
1	Disease Progression 01/2022
1	Viremia 12/2021
1	Communicable Diseases (Infectious Diseases) 09/2021

Drug/Important Bio-Agent (IBA)

12	Antiviral Agents (Antivirals)IBA 04/2024 - 03/2016
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2001
7	Hepatitis B e AntigensIBA 10/2022 - 11/2007
6	DNA (Deoxyribonucleic Acid)IBA 02/2020 - 09/2002
5	AntigensIBA 07/2020 - 02/2000
4	LigandsIBA 02/2023 - 01/2008
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2020 - 01/2016
4	InterferonsIBA 10/2018 - 11/2016
3	Alanine Transaminase (SGPT)IBA 05/2023 - 03/2016
3	entecavir FDA Link 10/2022 - 03/2016
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 06/2021
3	Indicators and Reagents (Reagents)IBA 05/2022 - 01/2008
3	AntibodiesIBA 01/2019 - 01/2001
3	Monoclonal AntibodiesIBA 01/2008 - 02/2000
2	NucleotidesIBA 10/2023 - 08/2023
2	peginterferon alfa-2a (Pegasys)FDA Link 10/2022 - 10/2018
2	RNA (Ribonucleic Acid)IBA 05/2022 - 04/2017
2	salinomycinIBA 01/2022 - 01/2020
2	CholesterolIBA 07/2019 - 10/2001
2	Therapeutic UsesIBA 01/2019 - 01/2001
2	nedaplatinIBA 03/2018 - 01/2012
2	GadoliniumIBA 06/2017 - 08/2016
2	Contrast MediaIBA 06/2017 - 08/2016
2	Hormones (Hormone)IBA 04/2017 - 01/2000
2	Triglycerides (Triacylglycerol)IBA 04/2017 - 10/2001
2	SteroidsIBA 04/2017 - 01/2006
2	Estrogens (Estrogen)FDA Link 12/2016 - 01/2006
2	Trinitrotoluene (TNT)IBA 01/2008 - 01/2001
2	Interleukin-2 (IL2)IBA 01/2008 - 08/2007
2	ChemokinesIBA 01/2008 - 08/2007
2	CytokinesIBA 01/2008 - 01/2002
2	Uroplakin IIIIBA 06/2001 - 11/2000
1	semaglutideIBA 01/2024
1	bicyclolIBA 01/2024
1	LipidsIBA 10/2023
1	Reverse Transcriptase InhibitorsIBA 10/2023
1	Tenofovir (Viread)FDA Link 10/2023
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2023
1	NucleosidesIBA 08/2023
1	Omalizumab (Xolair)FDA Link 03/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2023
1	Infliximab (Remicade)FDA Link 02/2023
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2023
1	ParaffinIBA 10/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Transaminases (Aminotransferases)IBA 06/2021

Therapy/Procedure

23	Therapeutics 04/2024 - 01/2000
5	Radiotherapy 01/2022 - 01/2011
2	Gastrectomy 05/2022 - 02/2022
2	Palliative Care (Palliative Therapy) 05/2022 - 02/2022
2	Plasma Exchange 05/2020 - 10/2018
2	Artificial Liver (Bioartificial Liver) 05/2020 - 10/2018
2	Immunotherapy 06/2016 - 01/2008
2	Drug Therapy (Chemotherapy) 01/2012 - 01/2000
1	Aftercare (After-Treatment) 03/2023
1	Conservative Treatment 05/2022
1	Length of Stay 05/2022